These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3348224

  • 1. Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis.
    Briceland LL, Quintiliani R, Nightingale CH.
    Am J Hosp Pharm; 1988 Jan; 45(1):122-5. PubMed ID: 3348224
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacy initiatives to reduce clindamycin use.
    Greene SA, Record KE, Rapp RP, Amerson AB, Bell RM, Piecoro JJ.
    Am J Hosp Pharm; 1986 May; 43(5):1210-3. PubMed ID: 3717177
    [Abstract] [Full Text] [Related]

  • 4. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM, Messick CR.
    Am J Hosp Pharm; 1994 Aug 01; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [Abstract] [Full Text] [Related]

  • 5. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
    Michael KA, Henderson PL, Newman RB, Blackwelder EN, Caldwell RD.
    Hosp Pharm; 1992 Mar 01; 27(3):213-6. PubMed ID: 10116721
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metronidazole: an alternate therapy for antibiotic-associated colitis.
    Cherry RD, Portnoy D, Jabbari M, Daly DS, Kinnear DG, Goresky CA.
    Gastroenterology; 1982 May 01; 82(5 Pt 1):849-51. PubMed ID: 7060906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    Schweitzer MA, Sweiss I, Silver DL, Stellato TA.
    Am Surg; 1996 Jul 01; 62(7):603-7; discussion 607-8. PubMed ID: 8651560
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of antibiotic-associated pseudomembranous colitis.
    Gross MH.
    Clin Pharm; 1985 Jul 01; 4(3):304-10. PubMed ID: 3891202
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Target drug monitoring: a cost-effective service provided by staff pharmacists.
    Chrymko MM, Meyer JD, Kelly WN.
    Hosp Pharm; 1994 Apr 01; 29(4):347, 350-2. PubMed ID: 10133463
    [Abstract] [Full Text] [Related]

  • 18. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA, Bakkanagari SR, Moorthi KM, Davis MB.
    Clin Infect Dis; 2007 Aug 01; 45(3):302-7. PubMed ID: 17599306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
    Meuwissen SG, Rietra PJ, Mulder CJ, Reiss M, Visser J, Van Leeuwen AM.
    Neth J Med; 1981 Aug 01; 24(1):10-3. PubMed ID: 7207690
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.